Skip to main content

Radiostereometric Analysis

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Medacta
MedactaSwitzerland - Castel San Pietro
1 program
RSA Masterloc Study AustraliaN/A1 trial
Active Trials
NCT05818878Active Not Recruiting26Est. Nov 2025
Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
RSA imagesN/A1 trial
Active Trials
NCT01754155Unknown55Est. Dec 2018
Halifax Biomedical
1 program
RSA imagesN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MedactaRSA Masterloc Study Australia
Zimmer BiometRSA images

Clinical Trials (2)

Total enrollment: 81 patients across 2 trials

NCT05818878MedactaRSA Masterloc Study Australia

RSA Masterloc Study Australia

Start: Sep 2020Est. completion: Nov 202526 patients
N/AActive Not Recruiting

A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene

Start: Jan 2013Est. completion: Dec 201855 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.